Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
International Journal of Clinical Pharmacy
|
April 22, 2014
Pharmaceutical care: the PCNE definition 2013
Samuel S Allemann, J W Foppe van Mil, Lea Botermann, et al.
JAMA Network Open
|
October 28, 2020
National Poison Center Calls Before vs After Availability of High-Dose Acetaminophen (Paracetamol) Tablets in Switzerland
Adrian Martinez-De la Torre, Stefan Weiler, Dominic Stefan Bräm, et al.
Pharmacogenomics
|
September 15, 2023
Severe systemic adverse reactions to ophthalmic timolol in a <i>CYP2D6</i> homozygous <i>*4</i> allele carrier: a case report
Anna Bollinger, Chiara Jeiziner, Henriette E Meyer Zu Schwabedissen, et al.
Pharmacy (Basel, Switzerland)
|
February 25, 2025
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions-A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
Anna Bollinger, Melissa Semedo Fortes, Henriette E Meyer Zu Schwabedissen, et al.
Frontiers in Psychiatry
|
May 14, 2024
Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction
Florine M Wiss, Samuel S Allemann, Henriette E Meyer Zu Schwabedissen, et al.
Plos One
|
April 25, 2024
Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study
Katharina Rekk, Isabelle Arnet, Fine Dietrich, et al.
Patient Preference and Adherence
|
August 7, 2025
Generative AI/LLMs for Plain Language Medical Information for Patients, Caregivers and General Public: Opportunities, Risks and Ethics
Avishek Pal, Tenzin Wangmo, Trishna Bharadia, et al.
Pharmacogenomics and Personalized Medicine
|
May 27, 2026
Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters
Marietta M Roth, Aline Bencastro, Christoph R Meier, et al.
Pharmacogenomics and Personalized Medicine
|
September 2, 2025
The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data
Nina L Wittwer, Christoph R Meier, Carola A Huber, et al.
European Journal of Neurology
|
July 2, 2024
Determinants of adherence to post-stroke/transient ischemic attack secondary prevention medications: A cohort study
Damien Hoarau, Inès Ramos, Anne Termoz, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
International Journal of Clinical Pharmacy
|
April 22, 2014
Pharmaceutical care: the PCNE definition 2013
Samuel S Allemann, J W Foppe van Mil, Lea Botermann, et al.
JAMA Network Open
|
October 28, 2020
National Poison Center Calls Before vs After Availability of High-Dose Acetaminophen (Paracetamol) Tablets in Switzerland
Adrian Martinez-De la Torre, Stefan Weiler, Dominic Stefan Bräm, et al.
Pharmacogenomics
|
September 15, 2023
Severe systemic adverse reactions to ophthalmic timolol in a <i>CYP2D6</i> homozygous <i>*4</i> allele carrier: a case report
Anna Bollinger, Chiara Jeiziner, Henriette E Meyer Zu Schwabedissen, et al.
Pharmacy (Basel, Switzerland)
|
February 25, 2025
Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions-A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
Anna Bollinger, Melissa Semedo Fortes, Henriette E Meyer Zu Schwabedissen, et al.
Frontiers in Psychiatry
|
May 14, 2024
Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction
Florine M Wiss, Samuel S Allemann, Henriette E Meyer Zu Schwabedissen, et al.
Plos One
|
April 25, 2024
Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study
Katharina Rekk, Isabelle Arnet, Fine Dietrich, et al.
Patient Preference and Adherence
|
August 7, 2025
Generative AI/LLMs for Plain Language Medical Information for Patients, Caregivers and General Public: Opportunities, Risks and Ethics
Avishek Pal, Tenzin Wangmo, Trishna Bharadia, et al.
Pharmacogenomics and Personalized Medicine
|
May 27, 2026
Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters
Marietta M Roth, Aline Bencastro, Christoph R Meier, et al.
Pharmacogenomics and Personalized Medicine
|
September 2, 2025
The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data
Nina L Wittwer, Christoph R Meier, Carola A Huber, et al.
European Journal of Neurology
|
July 2, 2024
Determinants of adherence to post-stroke/transient ischemic attack secondary prevention medications: A cohort study
Damien Hoarau, Inès Ramos, Anne Termoz, et al.
Page
of 5